Swedbank AB trimmed its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 415,715 shares of the company’s stock after selling 12,765 shares during the quarter. Swedbank AB’s holdings in Cardinal Health were worth $85,429,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Strategy Asset Managers LLC acquired a new stake in Cardinal Health in the third quarter valued at approximately $775,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Cardinal Health by 15.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock worth $5,938,000 after buying an additional 5,030 shares during the period. Versor Investments LP acquired a new stake in shares of Cardinal Health during the third quarter worth $2,090,000. Machina Capital S.A.S. lifted its stake in shares of Cardinal Health by 248.0% during the third quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock worth $4,246,000 after buying an additional 19,280 shares during the period. Finally, Atle Fund Management AB lifted its stake in shares of Cardinal Health by 13.1% during the third quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after buying an additional 3,500 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms have recently commented on CAH. UBS Group set a $260.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Friday, February 6th. Argus lifted their price objective on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday. Finally, Leerink Partners reiterated an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a research note on Monday, March 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $241.80.
Cardinal Health Price Performance
NYSE CAH opened at $200.42 on Friday. The company has a market capitalization of $46.94 billion, a PE ratio of 30.64, a P/E/G ratio of 1.19 and a beta of 0.53. The company has a fifty day moving average of $205.21 and a 200 day moving average of $208.69. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.19%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
